Brand names and generic drugs, 1974 : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974.

Volumes:

There are no volumes